Clinical Trial Update: Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study [NA]

View source ↗

Summary

A randomized, double-blind, placebo-controlled multicenter trial protocol evaluating whether Fuzheng Huayu Tablets can reduce re-decompensation events in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Hepatitis Cirrhosis

Drugs mentioned

• Fuzheng Huayu Tablets

Snippet

Sponsor: Zhiyun Yang | Conditions: Decompensated Hepatitis B Cirrhosis | NA | Status: NOT_YET_RECRUITING